Even though the clinical relevance in the aforementioned cardiovascular chance factor alterations by tirzepatide might be assessed within the prepared cardiovascular final result research SURPASS-CVOT ( "sort":"scientific-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-analysi